FDA Officials Say They’re Focused on Cutting Red Tape for New Drugs

Breakthrough products should be able to be brought to market quicker than is currently allowed, agency officials say.

The U.S. Food and Drug Administration (FDA) in White Oak, Md., on June 5, 2023. Madalina Vasiliu/The Epoch Times

The Food and Drug Administration is looking to cut down on the time to bring new products to market, two of the agency’s top officials said on June 10.

FDA reviews that usually took a year were completed in weeks during the COVID-19 pandemic, which is “clear demonstration that rapid or instant reviews are possible,” Dr. Marty Makary, the FDA’s commissioner, and Dr. Vinay Prasad, director of the FDA’s Center for Biologics Evaluation and Research, said in a viewpoint published by the Journal of the American Medical Association.